Table 1.
Umbilical cord allograft suspension mediator content as determined by ELISA
| Mediator (pg/mL) | Mean ± SEM | Coefficient of variance within donor (CV %) |
|---|---|---|
| IFNg | 184.5 ± 32.1 | 30.1 |
| IL-1a | 969.3 ± 5.9 | 1.1 |
| IL-1ra | 317.9 ± 15.6 | 8.5 |
| IL-1ra/IL-1a | 0.3 ± 0.02 | 9.6 |
| IL-2 | 839.7 ± 19.9 | 4.1 |
| IL-4 | 85.5 ± 21.7 | 43.9 |
| IL-8 | 870.8 ± 30.4 | 6.1 |
| IL-10 | 95.1 ± 22.5 | 40.9 |
| IL-15 | 689.2 ± 20.3 | 5.1 |
| MCP | 1175.8 ± 25.7 | 3.8 |
| VEGF | 833.7 ± 26.0 | 5.4 |
| HA | 42.3 ± 3.6 | 14.9 |
N = 3; samples run in triplicate
IFNg interferon gamma,
IL-1 interleukin-1a,
IL-1ra interleukin-1 receptor antagonist,
IL-2, −4, −8, −10, and −15 the corresponding interleukin,
MCP-1 monocyte chemoattractant protein-1,
VEGF vascular endothelial growth factor,
HA hyaluronic acid